Back to search results

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Abroad (travel likely)RecruitingPHASE2

Conditions

Cirrhosis · Cirrhosis, Liver · Cirrhosis Early · Cirrhosis Due to Hepatitis B · Cirrhosis Advanced · Cirrhosis Infectious · Cirrhosis Alcoholic · Cirrhosis Due to Hepatitis C

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California San Diego NAFLD Research Center, La Jolla, California, United States

    Contact: Study coordinator (Rohit Loomba) · roloomba@health.ucsd.edu

  • Keck Medical Center of USC, Los Angeles, California, United States

    Contact: Study coordinator (Norah Terrault) · norah.terrault@med.usc.edu

  • LAC + USC Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Norah Terrault) · norah.terrault@med.usc.edu

  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States

    Contact: Study coordinator (Mandana Khalili) · Mandana.Khalili@ucsf.edu

  • UCSF Medical Center, San Francisco, California, United States

    Contact: Study coordinator (Bilal Hameed) · bilal.hameed@ucsf.edu

  • University of Miami Health System, Miami, Florida, United States

    Contact: Study coordinator (David Goldberg) · dsgoldberg@med.miami.edu

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Elliot Tapper) · etapper@med.umich.edu

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Doug A. Simonetto, MD) · simonetto.douglas@mayo.edu · (507) 284-2511

  • New York Presbyterian/Weill Cornell, New York, New York, United States

    Contact: Study coordinator (Robert Brown) · rsb2005@med.cornell.edu

  • Columbia University Iriving School of Medicine, New York, New York, United States

    Contact: Study coordinator (Elizabeth Verna) · ev77@cumc.columbia.edu

  • Duke Liver Center, Durham, North Carolina, United States

    Contact: Study coordinator (Cynthia Ann Moylan, MD, MHS, MS) · cynthia.moylan@duke.edu · 919-681-4044
    Contact: Study coordinator (Mariko Kopping) · mariko.kopping@duke.edu

  • Cleveland Clinic, Cleveland, Ohio, United States

  • Virginia Commonwealth University, Richmond, Virginia, United States

    Contact: Study coordinator (Arun Sanyal) · arun.sanyal@vcuhealth.org
Study leads

  • Abigail Smith, PhD

    Principal Investigator

    Northwestern University

View source on ClinicalTrials.gov(opens in a new tab)